---
# System prepended metadata

title: Untitled

---

Parkinson’s Treatment Market Investment Opportunities Forecast To 2028

The global parkinson’s treatment market size was valued at USD 4,482.4 million in 2021 and is poised to grow at a significant CAGR of 12.4% during the forecast period 2022-28. Parkinson’s disease like the combination or multiple therapies in order to prolong the actions of the continuous stimulation of dopaminergic drugs, neurostimulation devices approvals, neuroprotective therapies which slows the prognosis of Parkinson’s disease are anticipated to drive Parkinson’s disease treatment market globally. Factors such as loss of patent protection for some of the drugs, rise in competition from generic drugs of Parkinsonism, huge unmet needs in the market, delaying development and launch of new products in the market are the few restraints for the Parkinson’s disease treatment market growth.  

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/global-parkinsons-treatment-market/    

![](https://i.imgur.com/uOKBJ44.jpg)


Rising prevalence of the disease and increasing demand for new drug therapies are the key drivers of the market. About 6.3 million people suffer from Parkinson’s disease according to the European Brain Council.

The global parkinson’s treatment market segmentation:
1) By Drug Class: Monoamine Oxidase Inhibitors (MAO), Dopamine Precursors, Catechol-o-methyltransferase Inhibitors (COMT), Peripheral Decarboxylase Inhibitors, Others  
2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies.

Request sample report at  https://precisionbusinessinsights.com/request-sample?product_id=16235                                                       

Geographically, the global Parkinson’s Treatment Market is segmented into five regions namely, Latin America, North America, Asia-Pacific, Europe, and the Middle East and Africa. North America dominates the global market for Parkinson’s disease treatment owing to the good reimbursement policies and high prevalence of the disease.     

The parkinson’s treatment key players are Salix Pharmaceuticals (U.S.), GlaxoSmithKline Plc. (U.K.), Wockhardt Limited (India), Impax Laboratories, Inc. (U.S), Novartis AG (Switzerland), Mylan N.V (U.S), Teva Pharmaceutical Industries Ltd.(Israel)

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747